I am a board-certified hematologist and oncologist specializing in the use of stem cell transplantation to treat patients with hematologic malignancies (cancers that arise from blood cells). I work as part of a multidisciplinary team of transplantation specialists who treat patients with these diseases.
As a clinical researcher, my work focuses on identifying risk factors associated with relapse after allogeneic stem cell transplantation for myelodysplastic syndrome and acute muyelogenous leukemia. Together with my colleagues I am developing protocols for early post-transplant intervention to prevent relapse.
- Clinical Expertise: Stem Cell Transplanttion for Hematolgic Malignancies
- Languages Spoken: English; Hebrew
- Education: MD, Joyce and Irving Goldman Medical School, Ben-Gurion University (Israel)
- Residencies: Jacobi Medical Center (New York)
- Fellowships: Montefiore Medical Center (New York); Memorial Sloan Kettering Cancer Center
- Board Certifications: Internal Medicine; Medical Oncology; Hematology
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Roni Tamari
- A Phase II Study of 5'-Azacitidine to Prevent Recurrence in Patients Who Had a Donated Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndromes
- A Phase II Study of T-Cell Depleted Stem Cell Boost for Adults and Children with Low Blood Counts After Allogeneic Stem Cell Transplantation
Clinical Trials Co-Investigated by Roni Tamari
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more